Naomi Takahashi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.

Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.

Journal: European journal of dermatology : EJD

Published: November 01, 2018

Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.

Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.

Journal: European journal of dermatology : EJD

Published: June 29, 2018

Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma.

Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma.

Journal: The Journal of dermatology

Published: April 02, 2018

Trousseau syndrome associated with cutaneous squamous cell carcinoma.

Trousseau syndrome associated with cutaneous squamous cell carcinoma.

Journal: The Journal of dermatology

Published: February 24, 2018

Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome.

Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome.

Journal: The Journal of investigative dermatology

Published: January 15, 2018

Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.

Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.

Journal: The Journal of dermatology

Published: September 15, 2017

Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome.

Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome.

Journal: The Journal of dermatology

Published: June 14, 2017

Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.

Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.

Journal: Acta dermato-venereologica

Published: June 10, 2017

Increased endocan expression in lesional skin and decreased endocan expression in sera in atopic dermatitis.

Increased endocan expression in lesional skin and decreased endocan expression in sera in atopic dermatitis.

Journal: The Journal of dermatology

Published: May 14, 2017

Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T-cell Lymphoma.

Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T-cell Lymphoma.

Journal: Acta dermato-venereologica

Published: January 26, 2017

BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines.

BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines.

Journal: Archives of dermatological research

Published: November 21, 2016

Paradoxical antitumor effects of pazopanib in a cutaneous angiosarcoma patient.

Paradoxical antitumor effects of pazopanib in a cutaneous angiosarcoma patient.

Journal: The Journal of dermatology

Published: October 12, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026